Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
UFH Thromboprophylaxis Dosing in Antepartum Hospitalizations
NCT04635839Phase 4Completed
- Sponsor
- University of California, Los Angeles
- Start
- Dec 2020
- Primary completion
- Mar 2022
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of heparin in venous thromboembolism (VTE), sponsored by University of California, Los Angeles. Started Dec 2020; status: completed.
02
Drugs
heparin
03
Conditions
venous thromboembolism (VTE)
Beyond the preview
Go deeper on NCT04635839.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04635839.